back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-04-09 15:46 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-34,509 vol |
1,187 | |
| Filed 2025-04-09 15:45 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-966 vol |
33 | |
| Filed 2025-01-20 16:31 Tx date 2025-01-15 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,466 vol |
35,696 | |
| Filed 2025-01-15 11:38 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-14,001 vol |
999 | |
| Filed 2025-01-15 11:35 Tx date 2024-04-10 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-166 vol |
37,162 | |
| Filed 2023-08-18 13:26 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-14,000 vol |
||
| Filed 2024-02-08 09:53 Tx date 2024-02-05 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,333 vol |
37,328 | |
| Filed 2023-08-18 13:27 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-476,005 vol |
33,995 | |
| Filed 2023-08-18 13:26 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-14,000 vol |
1,000 | |
| Filed 2023-06-05 10:10 Tx date 2023-06-01 |
$MSCL
Satellos Bioscience Inc. |
Whitehead, Warren
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+246,869 vol |
448,389 | |
| Filed 2023-01-24 15:54 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
510,000 | |
| Filed 2022-10-06 17:27 Tx date 2022-10-06 |
$MSCL
Satellos Bioscience Inc. |
Whitehead, Warren
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+70,000 vol |
201,520 | |
| Filed 2022-01-20 18:34 Tx date 2022-01-18 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
410,000 | |
| Filed 2021-08-30 18:02 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Whitehead, Warren
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
131,520 | ||
| Filed 2021-06-23 17:24 Tx date 2021-06-22 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,419.20
-9,600 vol $4.00 each |
15,000 | |
| Filed 2021-06-23 17:22 Tx date 2021-06-21 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-63,848.40
-15,400 vol $4.15 each |
24,600 | |
| Filed 2021-01-06 19:54 Tx date 2021-01-04 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
360,000 | |
| Filed 2020-12-29 07:27 Tx date 2020-12-22 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-53,003
-10,000 vol $5.30 each |
40,000 | |
| Filed 2020-12-29 07:27 Tx date 2020-12-22 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-51,745
-10,000 vol $5.17 each |
50,000 | |
| Filed 2020-12-29 07:26 Tx date 2020-12-22 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$52,000
+20,000 vol $2.60 each |
60,000 |